In the early 1970s, biochemist Loren Pickart made an unexpected observation. When older human liver tissue was exposed to a fraction of young blood plasma, it began producing proteins at rates comparable to much younger tissue. The molecule responsible turned out to be remarkably small: a tripeptide called glycyl-L-histidyl-L-lysine, or GHK, which naturally binds copper ions to form the complex known as GHK-Cu.
Since that discovery, GHK-Cu has become one of the most studied peptides in regenerative science. Researchers have documented its involvement in wound repair, tissue remodeling, gene expression, antioxidant defense, and more. What makes it particularly interesting is that it occurs naturally in human blood plasma, with concentrations averaging around 200 ng/mL at age 20 and declining to roughly 80 ng/mL by age 60.
Note: GHK-Cu is sold strictly for research purposes. It is not intended for human or animal use. Nothing in this article constitutes medical advice.
GHK-Cu is a copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine. Its molecular weight is approximately 403.9 Da, making it one of the smallest bioactive peptides known to science. The “Cu” designation refers to the copper ion that GHK binds with high affinity, and this copper-binding property is central to its biological activity.
One of the most important aspects of GHK-Cu is that it effectively silences the redox activity of free copper ions. Unbound copper can catalyze the production of harmful reactive oxygen species (ROS) through Fenton-type reactions. By chelating copper, GHK delivers it to cells in a non-toxic form, allowing the metal to participate in essential enzymatic processes without causing oxidative damage.
How GHK-Cu Works: Mechanisms Under Investigation
Gene Expression on a Massive Scale
Perhaps the most striking finding about GHK-Cu is its capacity to influence gene expression. Using the Broad Institute’s Connectivity Map database, researchers have documented that GHK modulates the expression of more than 4,000 human genes, representing over 30% of the human genome that has been studied. Of the affected genes, approximately 59% show increased expression while 41% show decreased expression.
Key gene categories affected include 84 DNA repair genes (predominantly upregulated), genes governing inflammatory signaling (downregulated), and genes associated with tissue remodeling. Researchers have noted that this pattern broadly corresponds to shifting gene expression from aged or damaged profiles toward healthier states.
The SIRT1/STAT3 Pathway
A 2025 study published in Frontiers in Pharmacology identified a specific molecular mechanism for GHK-Cu’s anti-inflammatory effects. The research demonstrated that GHK-Cu acts as a novel activator of SIRT1 (NAD-dependent deacetylase sirtuin-1), binding directly to the protein with a binding energy of -8.75 kcal/mol. This activation, in turn, suppresses phosphorylated STAT3, a key player in inflammatory signaling. The study confirmed that GHK-Cu’s protective effects in a colitis model depended on this SIRT1/STAT3 signaling axis.
Collagen Synthesis and ECM Remodeling
GHK-Cu has been shown to stimulate fibroblasts to produce collagen, elastin, proteoglycans, and glycosaminoglycans. A 2023 study in the Journal of Cosmetic Dermatology demonstrated that combining GHK-Cu with hyaluronic acid achieved a 25.4-fold increase in collagen IV synthesis in cell-based assays and a 2.03-fold increase in ex vivo skin tests. These findings illustrate the peptide’s role in extracellular matrix (ECM) remodeling, a process critical to tissue repair and structural integrity.
Researchers investigating BPC-157 and TB-500 alongside GHK-Cu have noted complementary mechanisms in tissue repair pathways, which is one reason these peptides are sometimes studied together in blend formulations like GLOW and KLOW.
All compounds discussed here are for laboratory research only and are not approved for human consumption or therapeutic use.
GHK-Cu’s effects on wound repair have been documented extensively. A comprehensive 2025 review in the International Journal of Medical Sciences covering studies from 2016 to 2025 confirmed that GHK-based formulations, including nanoparticle conjugates and hydrogels, enhance fibroblast migration, ECM remodeling, collagen and elastin synthesis, and wound closure while also providing antimicrobial activity. These properties make GHK-Cu a versatile research tool for studying regenerative processes.
Neuroprotection and Cognitive Research
A 2023 study from the University of Washington investigated intranasal delivery of GHK-Cu in aging mice. Animals treated with GHK-Cu showed enhanced cognitive performance in spatial memory and learning navigation tasks, along with decreased markers of neuroinflammation and axonal damage compared to saline-treated controls. Earlier gene expression analyses had already shown that GHK modulates multiple genes relevant to nervous system function, including those involved in antioxidant defense, inflammation regulation, and neural development.
Antioxidant Defense Systems
GHK-Cu supports antioxidant defenses through multiple pathways. It increases the activity of superoxide dismutase (SOD), blocks the formation of reactive carbonyl species, detoxifies acrolein (a toxic product of lipid peroxidation), and protects keratinocytes from ultraviolet B radiation damage. A 2024 study in Colloids and Surfaces B: Biointerfaces demonstrated that GHK-Cu loaded into nanocarrier systems regulated Nrf2, SIRT1, and PEG2/COX-2 signaling pathways, effectively counteracting cellular inflammation, senescence, and apoptosis from oxidative damage.
Advanced Delivery Systems
A growing body of research focuses on improving GHK-Cu delivery. A 2023 study in Bioactive Materials developed a thermodynamically stable ionic liquid microemulsion that improved local delivery of copper peptides by approximately threefold while retaining biological function. In mouse models, this formulation activated the Wnt/beta-catenin signaling pathway and stimulated VEGF and HGF secretion. Separately, a 2025 study in Colloids and Surfaces B created an injectable hydroxyapatite microsphere filler loaded with GHK-Cu that demonstrated sustained release over seven days with significant anti-inflammatory and antioxidant properties.
Cancer Gene Expression Research
Using Connectivity Map analyses, researchers found that GHK reversed the pathological expression of 70% of genes in a gene signature associated with metastasis-prone colon cancer. Further work demonstrated that GHK upregulates tumor suppressor proteins and modulates genes in breast cancer (MCF7) and prostate cancer (PC3) cell lines. Additionally, GHK has been shown to shift gene expression in COPD lung tissue from a destructive pattern toward healthy remodeling.
What Researchers Should Know
GHK-Cu’s properties span an unusually broad range of biological systems, from skin and connective tissue to the brain and immune system. Several features make it a particularly valuable research compound:
Natural origin: Found in human plasma, saliva, and urine, with well-characterized age-related decline
Copper delivery: Provides non-toxic copper transport for enzymatic processes
Gene-level effects: Influences over 4,000 genes across DNA repair, inflammation, and tissue remodeling pathways
Multiple delivery routes: Studied via topical, intranasal, and injectable delivery methods
Synergistic potential: Investigated alongside other peptides for complementary mechanisms
This article is intended for educational and informational purposes only. GHK-Cu and all products mentioned are sold exclusively for in vitro research. They are not drugs, supplements, or intended for human or animal use.
GHK-Cu is a complex of the tripeptide glycyl-L-histidyl-L-lysine bound to a copper(II) ion. It has a molecular weight of approximately 403.9 Da and occurs naturally in human blood plasma, urine, and saliva.
How was GHK-Cu discovered?
Biochemist Loren Pickart discovered GHK in 1973 while studying why young blood plasma caused aged liver tissue to produce proteins at youthful rates. The active molecule was identified as the tripeptide GHK, which naturally forms a complex with copper.
How many genes does GHK-Cu affect?
Research using the Broad Institute’s Connectivity Map has shown that GHK modulates the expression of more than 4,000 human genes. These include genes involved in DNA repair, inflammation, tissue remodeling, and antioxidant defense.
Why does GHK-Cu decline with age?
Serum levels of GHK average approximately 200 ng/mL at age 20 and drop to around 80 ng/mL by age 60. The exact reasons for this decline are still under investigation, but it correlates with age-related reductions in tissue repair and regenerative capacity.
What is the SIRT1 pathway connection?
A 2025 study identified GHK-Cu as a novel SIRT1 activator. Molecular docking analysis showed that GHK-Cu binds directly to SIRT1 with a binding energy of -8.75 kcal/mol. This activation suppresses inflammatory STAT3 signaling, providing a molecular explanation for many of GHK-Cu’s observed anti-inflammatory effects.
Can GHK-Cu be combined with other peptides in research?
Yes. GHK-Cu is frequently studied alongside other peptides such as BPC-157 and TB-500 due to their complementary mechanisms in tissue repair. Blend formulations containing these peptides are available for research applications.
Is GHK-Cu approved for human use?
No. GHK-Cu sold by research suppliers is intended strictly for in vitro laboratory research. It is not a drug, supplement, or approved for human or animal consumption.
References
Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018;19(7):1987. PubMed
Pickart L, Vasquez-Soltero JM, Margolina A. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. Biomed Res Int. 2015;2015:648108. PubMed
Mao S, et al. Exploring the beneficial effects of GHK-Cu on an experimental model of colitis and the underlying mechanisms. Front Pharmacol. 2025;16:1551843. PubMed
Jiang F, et al. Synergy of GHK-Cu and hyaluronic acid on collagen IV upregulation via fibroblast and ex-vivo skin tests. J Cosmet Dermatol. 2023;22(9):2598-2604. PubMed
Tucker M, et al. Intranasal GHK peptide enhances resilience to cognitive decline in aging mice. bioRxiv. 2023. PubMed
Dou Y, et al. The potential of GHK as an anti-aging peptide. Aging Pathobiol Ther. 2020;2(1):58-61. PubMed
Pickart L, Vasquez-Soltero JM, Margolina A. The effect of the human peptide GHK on gene expression relevant to nervous system function and cognitive decline. Brain Sci. 2017;7(2):20. PubMed
Pickart L, Vasquez-Soltero JM, Margolina A. The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging. Oxid Med Cell Longev. 2012;2012:324832. PubMed
Wang Y, et al. Rigid-flexible nanocarriers loaded with active peptides for antioxidant and anti-inflammatory applications in skin. Colloids Surf B Biointerfaces. 2024;236:113772. PubMed
Liu T, et al. Thermodynamically stable ionic liquid microemulsions pioneer pathways for topical delivery and peptide application. Bioact Mater. 2023;32:502-513. PubMed
Hu D, et al. An injectable hydroxyapatite microsphere filler loaded with GHK-Cu tripeptide for anti-inflammatory and antioxidant. Colloids Surf B Biointerfaces. 2025;256:114982. PubMed
Dymek M, et al. Liposomes as carriers of GHK-Cu tripeptide for cosmetic application. Pharmaceutics. 2023;15(10):2485. PubMed
Adnan SB, et al. Exploring the role of tripeptides in wound healing and skin regeneration: a comprehensive review. Int J Med Sci. 2025;22(16):4175-4200. Full Text
Mortazavi SM, et al. Topically applied GHK as an anti-wrinkle peptide: advantages, problems and prospective. Bioimpacts. 2024;15:30071. PubMed
Pickart L, Margolina A. Modulation of gene expression in human breast cancer MCF7 and prostate cancer PC3 cells by the human copper-binding peptide GHK-Cu. OBM Genet. 2021;5(2):128. Full Text
Discover how copper-peptide GHK-Cu can transform your skin and hair, supporting collagen production, youthful elasticity, and fast wound-healing for a truly remarkable anti-aging boost. Dive into the science behind this powerhouse ingredient and see why copper-peptides are making waves in both clinical research and modern beauty routines!
Discover how GHRP-6 Acetate takes center stage as a powerful ghrelin booster, working behind the scenes to regulate appetite, intensify your gh-pulse, and support seamless recovery and performance in research environments. Dive in to learn why this innovative gh-secretagogue is a game-changer for exploring appetite and recovery solutions.
BPC-157 is a synthetic peptide derived from a protective protein found naturally in human gastric juice. Originally studied for its potential role in gastrointestinal healing, BPC-157 has attracted significant research interest for its effects on tissue repair, angiogenesis, and recovery processes. This peptide consists of 15 amino acids and has been the subject of numerous …
Examines mechanistic evidence for GHK-Cu’s role in the copper-dependent metalloprotease network. Reviews metalloproteinase regulation, copper-dependent enzyme activation, and gene expression modulation governing extracellular matrix homeostasis in fibroblast cell culture systems.
What Is GHK-Cu? The Copper Tripeptide Researchers Keep Studying
A Small Molecule With a Big Research Profile
In the early 1970s, biochemist Loren Pickart made an unexpected observation. When older human liver tissue was exposed to a fraction of young blood plasma, it began producing proteins at rates comparable to much younger tissue. The molecule responsible turned out to be remarkably small: a tripeptide called glycyl-L-histidyl-L-lysine, or GHK, which naturally binds copper ions to form the complex known as GHK-Cu.
Since that discovery, GHK-Cu has become one of the most studied peptides in regenerative science. Researchers have documented its involvement in wound repair, tissue remodeling, gene expression, antioxidant defense, and more. What makes it particularly interesting is that it occurs naturally in human blood plasma, with concentrations averaging around 200 ng/mL at age 20 and declining to roughly 80 ng/mL by age 60.
Note: GHK-Cu is sold strictly for research purposes. It is not intended for human or animal use. Nothing in this article constitutes medical advice.
$55.00Original price was: $55.00.$50.00Current price is: $50.00.What Exactly Is GHK-Cu?
GHK-Cu is a copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine. Its molecular weight is approximately 403.9 Da, making it one of the smallest bioactive peptides known to science. The “Cu” designation refers to the copper ion that GHK binds with high affinity, and this copper-binding property is central to its biological activity.
One of the most important aspects of GHK-Cu is that it effectively silences the redox activity of free copper ions. Unbound copper can catalyze the production of harmful reactive oxygen species (ROS) through Fenton-type reactions. By chelating copper, GHK delivers it to cells in a non-toxic form, allowing the metal to participate in essential enzymatic processes without causing oxidative damage.
How GHK-Cu Works: Mechanisms Under Investigation
Gene Expression on a Massive Scale
Perhaps the most striking finding about GHK-Cu is its capacity to influence gene expression. Using the Broad Institute’s Connectivity Map database, researchers have documented that GHK modulates the expression of more than 4,000 human genes, representing over 30% of the human genome that has been studied. Of the affected genes, approximately 59% show increased expression while 41% show decreased expression.
Key gene categories affected include 84 DNA repair genes (predominantly upregulated), genes governing inflammatory signaling (downregulated), and genes associated with tissue remodeling. Researchers have noted that this pattern broadly corresponds to shifting gene expression from aged or damaged profiles toward healthier states.
The SIRT1/STAT3 Pathway
A 2025 study published in Frontiers in Pharmacology identified a specific molecular mechanism for GHK-Cu’s anti-inflammatory effects. The research demonstrated that GHK-Cu acts as a novel activator of SIRT1 (NAD-dependent deacetylase sirtuin-1), binding directly to the protein with a binding energy of -8.75 kcal/mol. This activation, in turn, suppresses phosphorylated STAT3, a key player in inflammatory signaling. The study confirmed that GHK-Cu’s protective effects in a colitis model depended on this SIRT1/STAT3 signaling axis.
Collagen Synthesis and ECM Remodeling
GHK-Cu has been shown to stimulate fibroblasts to produce collagen, elastin, proteoglycans, and glycosaminoglycans. A 2023 study in the Journal of Cosmetic Dermatology demonstrated that combining GHK-Cu with hyaluronic acid achieved a 25.4-fold increase in collagen IV synthesis in cell-based assays and a 2.03-fold increase in ex vivo skin tests. These findings illustrate the peptide’s role in extracellular matrix (ECM) remodeling, a process critical to tissue repair and structural integrity.
Researchers investigating BPC-157 and TB-500 alongside GHK-Cu have noted complementary mechanisms in tissue repair pathways, which is one reason these peptides are sometimes studied together in blend formulations like GLOW and KLOW.
All compounds discussed here are for laboratory research only and are not approved for human consumption or therapeutic use.
$55.00Original price was: $55.00.$50.00Current price is: $50.00.Areas of Active Research
Wound Healing and Tissue Repair
GHK-Cu’s effects on wound repair have been documented extensively. A comprehensive 2025 review in the International Journal of Medical Sciences covering studies from 2016 to 2025 confirmed that GHK-based formulations, including nanoparticle conjugates and hydrogels, enhance fibroblast migration, ECM remodeling, collagen and elastin synthesis, and wound closure while also providing antimicrobial activity. These properties make GHK-Cu a versatile research tool for studying regenerative processes.
Neuroprotection and Cognitive Research
A 2023 study from the University of Washington investigated intranasal delivery of GHK-Cu in aging mice. Animals treated with GHK-Cu showed enhanced cognitive performance in spatial memory and learning navigation tasks, along with decreased markers of neuroinflammation and axonal damage compared to saline-treated controls. Earlier gene expression analyses had already shown that GHK modulates multiple genes relevant to nervous system function, including those involved in antioxidant defense, inflammation regulation, and neural development.
Antioxidant Defense Systems
GHK-Cu supports antioxidant defenses through multiple pathways. It increases the activity of superoxide dismutase (SOD), blocks the formation of reactive carbonyl species, detoxifies acrolein (a toxic product of lipid peroxidation), and protects keratinocytes from ultraviolet B radiation damage. A 2024 study in Colloids and Surfaces B: Biointerfaces demonstrated that GHK-Cu loaded into nanocarrier systems regulated Nrf2, SIRT1, and PEG2/COX-2 signaling pathways, effectively counteracting cellular inflammation, senescence, and apoptosis from oxidative damage.
Advanced Delivery Systems
A growing body of research focuses on improving GHK-Cu delivery. A 2023 study in Bioactive Materials developed a thermodynamically stable ionic liquid microemulsion that improved local delivery of copper peptides by approximately threefold while retaining biological function. In mouse models, this formulation activated the Wnt/beta-catenin signaling pathway and stimulated VEGF and HGF secretion. Separately, a 2025 study in Colloids and Surfaces B created an injectable hydroxyapatite microsphere filler loaded with GHK-Cu that demonstrated sustained release over seven days with significant anti-inflammatory and antioxidant properties.
Cancer Gene Expression Research
Using Connectivity Map analyses, researchers found that GHK reversed the pathological expression of 70% of genes in a gene signature associated with metastasis-prone colon cancer. Further work demonstrated that GHK upregulates tumor suppressor proteins and modulates genes in breast cancer (MCF7) and prostate cancer (PC3) cell lines. Additionally, GHK has been shown to shift gene expression in COPD lung tissue from a destructive pattern toward healthy remodeling.
What Researchers Should Know
GHK-Cu’s properties span an unusually broad range of biological systems, from skin and connective tissue to the brain and immune system. Several features make it a particularly valuable research compound:
Oath Research provides research-grade GHK-Cu with third-party purity testing. All certificates of analysis are publicly available.
This article is intended for educational and informational purposes only. GHK-Cu and all products mentioned are sold exclusively for in vitro research. They are not drugs, supplements, or intended for human or animal use.
$55.00Original price was: $55.00.$50.00Current price is: $50.00.Frequently Asked Questions
What is GHK-Cu made of?
GHK-Cu is a complex of the tripeptide glycyl-L-histidyl-L-lysine bound to a copper(II) ion. It has a molecular weight of approximately 403.9 Da and occurs naturally in human blood plasma, urine, and saliva.
How was GHK-Cu discovered?
Biochemist Loren Pickart discovered GHK in 1973 while studying why young blood plasma caused aged liver tissue to produce proteins at youthful rates. The active molecule was identified as the tripeptide GHK, which naturally forms a complex with copper.
How many genes does GHK-Cu affect?
Research using the Broad Institute’s Connectivity Map has shown that GHK modulates the expression of more than 4,000 human genes. These include genes involved in DNA repair, inflammation, tissue remodeling, and antioxidant defense.
Why does GHK-Cu decline with age?
Serum levels of GHK average approximately 200 ng/mL at age 20 and drop to around 80 ng/mL by age 60. The exact reasons for this decline are still under investigation, but it correlates with age-related reductions in tissue repair and regenerative capacity.
What is the SIRT1 pathway connection?
A 2025 study identified GHK-Cu as a novel SIRT1 activator. Molecular docking analysis showed that GHK-Cu binds directly to SIRT1 with a binding energy of -8.75 kcal/mol. This activation suppresses inflammatory STAT3 signaling, providing a molecular explanation for many of GHK-Cu’s observed anti-inflammatory effects.
Can GHK-Cu be combined with other peptides in research?
Yes. GHK-Cu is frequently studied alongside other peptides such as BPC-157 and TB-500 due to their complementary mechanisms in tissue repair. Blend formulations containing these peptides are available for research applications.
Is GHK-Cu approved for human use?
No. GHK-Cu sold by research suppliers is intended strictly for in vitro laboratory research. It is not a drug, supplement, or approved for human or animal consumption.
References
2 Day FAST Shipping
99%+ Purity Tests
Ships from Gilbert Arizona
USA Lab Tested
Free bacteriostatic water with every order.
Related Posts
Copper-Peptide GHK-CU: Stunning Anti-Aging Skin & Hair Benefits
Discover how copper-peptide GHK-Cu can transform your skin and hair, supporting collagen production, youthful elasticity, and fast wound-healing for a truly remarkable anti-aging boost. Dive into the science behind this powerhouse ingredient and see why copper-peptides are making waves in both clinical research and modern beauty routines!
GHRP-6 Acetate: Must-Have Ghrelin Booster for Effortless Recovery
Discover how GHRP-6 Acetate takes center stage as a powerful ghrelin booster, working behind the scenes to regulate appetite, intensify your gh-pulse, and support seamless recovery and performance in research environments. Dive in to learn why this innovative gh-secretagogue is a game-changer for exploring appetite and recovery solutions.
What is BPC-157 Peptide?
BPC-157 is a synthetic peptide derived from a protective protein found naturally in human gastric juice. Originally studied for its potential role in gastrointestinal healing, BPC-157 has attracted significant research interest for its effects on tissue repair, angiogenesis, and recovery processes. This peptide consists of 15 amino acids and has been the subject of numerous …
GHK-Cu and the Copper-Dependent Metalloprotease Network: Mechanisms in Cell Culture
Examines mechanistic evidence for GHK-Cu’s role in the copper-dependent metalloprotease network. Reviews metalloproteinase regulation, copper-dependent enzyme activation, and gene expression modulation governing extracellular matrix homeostasis in fibroblast cell culture systems.